Sign up for a free trial now

Login
Subscribe
Take a FREE Trial

About Us
Contact us
RSS

24 May 2013

Search

The Pharma Letter

Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe

Cholestagel Articles

Valeant continues buying spree getting rights to Cholestagel and Aczone in Canada

11 February 2011

Showing 1-1 of 1 articles

Go to beginning

Previous

1

Next

Go to end

Hot Topics
Most Read

Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
Is the diabetes market facing a blockbuster-free future?
Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
Boehringer Ingelheim gets FDA warning letter on cGMP failures

Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
Is the diabetes market facing a blockbuster-free future?
Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
Boehringer Ingelheim gets FDA warning letter on cGMP failures

© 2013 thepharmaletter.com

Home
RSS
About Us
Subscribe
Terms and Conditions
Article Archive

Site powered by WORKSsitebuilder CMS